During the past decade, Nang Kuang Pharmaceutical Co., LTD conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nang Kuang Pharmaceutical Co., LTD" #1 collaborator was "Buddhist Tzu Chi General Hospital" with 1 trials as a collaborator and "National Taiwan University Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Nang Kuang Pharmaceutical Co., LTD" are "Cardiovascular Disease" (1 trials), "Depression" (1 trials), "Hypercholesterolemia" (1 trials), "Pain" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Nang Kuang Pharmaceutical Co., LTD" in a lesser frequency.

Most popular intervention types in "Nang Kuang Pharmaceutical Co., LTD" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Dehypotin" (1 trials) and "Smilon®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nang Kuang Pharmaceutical Co., LTD" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Nang Kuang Pharmaceutical Co., LTD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Nang Kuang Pharmaceutical Co., LTD, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nang Kuang Pharmaceutical Co., LTD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".